Christina Heinlein

Christina Heinlein is a Regulatory Group Director in CMC Regulatory Affairs at Roche, based in Basel, Switzerland, where she joined in 2014. She is responsible for leading the global CMC regulatory strategy for Roche's New Technology, Innovation & Sustainability portfolio. Her work focuses on supporting and driving new technologies toward successful global Health Authority approvals. Christina holds a PhD in molecular biology from Leibniz Institute of Virology / University of Hamburg, Germany, and completed post-doctoral research in breast cancer at the Children's Medical Research Institute in Westmead/Sydney, Australia.